Takeda Partners With U.S. University On Basic Cancer Antibody Research
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical says it has signed an agreement with the University of California, San Francisco to collaborate on ways to synthesize an antibody for cancer metastasis